The University of Portsmouth is joining forces with brain tumour charity, Brainstrust and other partners to create a centre of excellence for brain tumour research on the South Coast.
Brain tumours are the most lethal and devastating tumours. They are the most common cause of death in children after accidents and the most common form of cancer in people under 40.
The new centre will focus entirely on dedicated laboratory-based brain tumour research in both adults and children.
Professor of Cellular & Molecular Neuro-oncology, Geoff Pilkington, who is leading the research team at Portsmouth, is chairing an open day at the University today to showcase the current facilities and to introduce major collaborators to the University.
Attendees include cricketer Alan Igglesden, the former Kent and England fast bowler, who was first diagnosed with a brain tumour several years ago. He is currently receiving treatment by Professor Pilkington and has long been a supporter of his work.
He and other brain tumour patients will hear about the current neuro-oncology research projects at Portsmouth and about the latest research in the field such as the development of new drug delivery systems to the brain.
Representatives from neurosurgical centres and charities which are currently funding research at the University will also attend, including leading brain tumour charities such as Ali’s Dream, Brain Tumour UK, and Charlie’s Challenge. Other attendees include senior clinical neuro-science staff from Southampton General Hospital and trustees, patrons and key supporters of Brainstrust.
Professor Pilkington said: “The aim of the collaboration between Brainstrust and Portsmouth University is to fund new specialist staff in neuro-oncology to further our research and to raise funds to buy equipment and provide essential running costs.”
Dr Helen Bulbeck is director and co-founder of Brainstrust, the Meg Jones tumour charity. She said: “Brain cancer research attracts relatively very little funding compared to other cancers, such as breast, bowel, lung and prostate. This is why raising awareness through this open day is so important.”
It is anticipated that several clinical leading neuro-oncology centres will provide vital tissues and clinical experience while the University will provide medical research programmes, training courses and a state of the art laboratory.
Those already on-board include Hurstwood Park Neurological Centre, Hayward's Heath, Maidstone NHS Hospitals, King's College Hospital, London & Charing Cross Hospital and the Institute of Neurology in London.
Professor Pilkington said that the centre would encourage institutions to collaborate in order for patients to benefit from a research informed environment.
Lisa Egan | alfa
How Humans and Machines Navigate Complex Situations
19.11.2018 | Max-Planck-Institut für Bildungsforschung
A gene activated in infant and young brains determines learning capacity in adulthood
13.11.2018 | Universitätsklinikum Hamburg-Eppendorf
Researchers from the University of Basel have reported a new method that allows the physical state of just a few atoms or molecules within a network to be controlled. It is based on the spontaneous self-organization of molecules into extensive networks with pores about one nanometer in size. In the journal ‘small’, the physicists reported on their investigations, which could be of particular importance for the development of new storage devices.
Around the world, researchers are attempting to shrink data storage devices to achieve as large a storage capacity in as small a space as possible. In almost...
The more objects we make "smart," from watches to entire buildings, the greater the need for these devices to store and retrieve massive amounts of data quickly without consuming too much power.
Millions of new memory cells could be part of a computer chip and provide that speed and energy savings, thanks to the discovery of a previously unobserved...
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
17.12.2018 | Studies and Analyses
17.12.2018 | Life Sciences
17.12.2018 | Power and Electrical Engineering